Tisuacryl® in esophageal surgery

Phase 2

• Conditions: Esophageal cancer or benign stenosis; Esophageal Neoplasms; Esophageal Stenosis; Gastrointestinal Neoplasms; Digestive System Neoplasms; Esophageal Diseases; Gastrointestinal Diseases; Digestive System Diseases

• Registration Number: RPCEC00000045
• Lead Sponsor: Center of Biomaterials of Havana University

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2008-09-12
• Last Update Posted: 19 August 2024

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 58

Inclusion Criteria

Adult patients, between 18 and 70 years old Patients of both sexes Patients that gave their informed consent to participate in the study Patients that fulfill one of the following diagnostic criteria: Resectable esophageal cancer phases I, II or III Benignant stenosis that requires esophageal resection with or without portions of the stomach. Both conditions were diagnosed by endoscopic techniques and biopsy.

Exclusion Criteria

Patient whose health conditions do not permit surgical treatment Patients with hypersensitivity to cyanoacrylates Patients with mental illness or severe psychological disorders, Pregnant women or during lactation Patients who don’t consent to participate in the study

Study & Design

• Study Type: Interventional
• Study Design: Not specified